Vijaya Diagnostic Centre Limited has announced the strategic acquisition of an integrated diagnostic business located in Guwahati, Assam. This acquisition, valued at approximately ₹46 crore, is structured as a slump sale and is expected to be EPS accretive from the outset. The deal represents a significant step in expanding Vijaya Diagnostic’s presence in the North-East region, leveraging the acquired entity’s established operating platform and customer base.
Strategic Expansion into North-East
Vijaya Diagnostic Centre Limited has announced a significant strategic move with the acquisition of an integrated diagnostic business in Guwahati, Assam. This transaction, valued at approximately ₹46 crore, is set to enhance the company’s footprint in the North-East region, which is seen as a natural extension of its growing presence in West Bengal.
Deal Structure and Financials
The acquisition is being carried out through a Slump Sale (BTA), with the transaction structure designed for immediate EPS accretion. The valuation of the deal is based on an approximate ~8-9x EBITDA multiple of the acquired entity’s adjusted FY26 IND AS EBITDA. The company anticipates the completion of the business transfer and operational handover by approximately November/December 2026.
Rationale and Synergies
The acquisition of Arya Wellness Centre, as it is known, is driven by several strategic factors. It provides immediate access to an established operating platform with existing infrastructure, clinical capabilities, and a recognized local presence. The business specializes in high-end imaging, interventional procedures, and histopathology, serving an established B2C customer base. Located strategically within Guwahati’s healthcare hub, the acquired entity boasts reputed clinicians and healthy financials, including an approximately 80% Gross Margin and ~21% EBITDA margin. This move is expected to strengthen Vijaya Diagnostic’s Eastern India presence and create a robust foundation for future expansion across the North-East.
Source: BSE
